Position in ARDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$997,616
-$1,660,596 QoQ
Shares Held
195,611
-55.9% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#71
of 250 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MONIMUS CAPITAL MANAGEMENT, LP holds $20,968,537 across 10 Biotechnology names. ARDX ranks #9 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
20,845 | $3,903,851 | |
| 2 | PRTA |
Prothena Corp Public Ltd Co
|
329,052 | $3,221,419 | |
| 3 | ABVX |
Abivax S.A.
|
21,644 | $2,884,279 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
66,502 | $2,594,243 | |
| 5 | QURE |
uniQure N.V.
|
51,066 | $2,352,099 | |
| 6 | QTTB |
Q32 Bio Inc.
|
132,036 | $1,682,138 | |
| 7 | ASMB |
Assembly Biosciences, Inc.
|
47,580 | $1,307,498 | |
| 8 | PEPG |
PepGen Inc.
|
587,688 | $1,057,838 |
All Filings in ARDX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $997,616 | 195,611 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,658,212 | 443,775 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,135,299 | 194,734 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,114,733 | 202,311 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $793,059 | 202,311 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $791,624 | 161,227 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||